Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 448, Issue 2, 2000, Pages 159-177

  Yeldandi, Anjana V ^a   Rao, M Sambasiva ^a   Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Lipid metabolism; Liver cancer; Non genotoxic; Non mutagenic; Peroxisome proliferators; Plasticizers; PPAR

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; CATALASE; CELL NUCLEUS RECEPTOR; CYTOCHROME P450; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LIPOFUSCIN; PEROXISOME PROLIFERATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RECEPTOR SUBTYPE; URATE OXIDASE;

CARCINOGENESIS; DNA ADDUCT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; LIPID OXIDATION; LIVER; LIVER TUMOR; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 0034678013     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00234-1     Document Type: Article

References (88)

1. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
2. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U. S. A. 907:1993;7915-7922.
3. Burdon R. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radical Biol. Med. 18:1995;775-794.
4. Vamecq J., Draye J.P. Pathophysiology of peroxisomal β-oxidation. Essays Biochem. 24:1989;115-225.
5. Van Den Munckhof R.J.M. In situ heterogeneity of peroxisomal oxidase activities: an update. Histochem. J. 28:1996;401-429.
6. De Duve C., Baudhuin P. Peroxisomes (microbodies and related particles). Physiol. Rev. 46:1966;323-357.
7. Boveris A., Oshino N., Chance B. The cellular production of hydrogen peroxide. Biochem. J. 128:1972;617-630.
8. Reddy J.K., Goel S.K., Nemali M.R., Carrino J.J., Laffler T.G., Reddy M.K., Sperbeck S.J., Osumi T., Hashimoto T., Lalwani N.D., Rao M.S. Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. U. S. A. 83:1986;1747-1751.
9. Hardwick J.P., Song B.J., Huberman E., Gonzalez F.J. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid w-hydroxylase (cytochrome P450LAw): identification of new cytochrome P-450 gene family. J. Biol. Chem. 262:1987;801-810.
10. Reddy J.K., Azarnoff D.L., Hignite C. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature. 283:1980;397-398.
11. Reddy J.K., Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12:1983;1-58.
12. Rao M.S., Reddy J.K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis. 8:1987;631-636.
13. Reddy J.K., Rao M.S. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res. 214:1989;63-68.
14. Gonzalez F.J., Peters J.M., Cattley R.C. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activated receptor α J. Natl. Cancer Inst. 90:1998;1702-1709.
15. Reddy J.K., Mannaerts G.P. Peroxisomal lipid metabolism. Annu. Rev. Nutr. 14:1994;343-370.
16. Nemali M.R., Reddy M.K., Usuda N., Reddy P.G., Comeau L.D., Rao M.S., Reddy J.K. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens. Toxicol. Appl. Pharmacol. 97:1989;72-87.
17. Yeldandi A.V., Yeldandi V. Molecular evolution of the urate oxidase-encoding gene and its functional significance. Gibson G.G., Lake B. Peroxisome: Biology and Importance in Toxicology and Medicine. 1993;205-215 Taylor & Francis, Washington, DC.
18. Yeldandi A.V., Yeldandi V.V., Kumar S., Murthy V.N., Wang X., Alvares K., Rao M.S., Reddy J.K. Molecular evolution of the urate oxidase-encoding gene in hominoid primates: nonsense mutations. Gene. 109:1991;281-284.
19. Wu X., Wuzny D.M., Lee C.C., Caskey C.T. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J. Mol. Evol. 43:1992;78-84.
20. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U. S. A. 78:1981;6859-6862.
21. Usuda N., Nakazawa A., Terasawa M., Reddy J.K., Nagata T. Immunocytochemical study of the ultrastructure of peroxisomes and the effect of peroxisome proliferators. Ann. N.Y. Acad. Sci. 804:1996;297-309.
22. Hashimoto T. Peroxisomal β-oxidation. Neurochem. Res. 24:1999;551-563.
23. Reddy J.K., Krishnakantha T.P. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science. 190:1975;787-789.
24. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
25. Zhu Y., Alvares K., Huang Q., Rao M.S., Reddy J.K. Cloning of a new member of the peroxisome proliferator activated receptor gene family from mouse liver. J. Biol. Chem. 268:1993;26817-26820.
26. Lee S.S., Pineau T., Drago J., Lee E.J., Owens J.W., Kroetz D.L., Fernandez-Salguero P.M., Westphal H., Gonzalez F.J. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15:1995;3012-3022.
27. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Grene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
28. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β, and -γ in the adult rat. Endocrinology. 137:1996;354-366.
29. Jain S., Pulukuri S., Zhu Y., Qi C., Kanwar Y.S., Yeldandi A.V., Rao M.S., Reddy J.K. Differential expression of the peroxisome proliferator-activated receptor γ (PPARγ) and its coactivators steroid receptor coactivator-1 and PPAR-binding protein PBP in the brown fat, urinary bladder, colon, and breast of the mouse. Am. J. Pathol. 153:1998;349-354.
30. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid activated transcription factor. Cell. 79:1994;1147-1156.
31. Tontonoz P., Nagy L., Alvarez J., Thomazy V.A., Evans R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
32. Johnson E.F., Palmer C., Hsu M. The peroxisome proliferator-activated receptor: transcriptional activation of the CYP4A6 gene. Ann. N.Y. Acad. Sci. 804:1996;373-386.
33. Kliewer S.A., Umesono K., Noonan D., Heyman R., Evans R.M. Convergence of 9-cis retinoic acid and peroxisome proliferator signaling pathways through heterodimer formation of their receptors. Nature. 358:1992;771-774.
34. Reddy J.K., Chu R. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon. Ann. N.Y. Acad. Sci. 804:1996;176-201.
35. Varanasi U., Chu R., Huang Q., Castellon R., Yeldandi A.V., Reddy J.K. Identification of peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271:1996;2147-2155. (see addendum in J. Biol. Chem. 273 (1998) 30842).
36. Tugwood J.D., Issemann I., Anderson R.G., Bundell K.R., McPheat W.L., Green S. The mouse peroxisome proliferator activated receptor recognizes response element in the 5′ flanking sequence of the rat acyl CoA oxidase gene. EMBO J. 11:1992;433-439.
37. Chu R., Lin Y., Rao M.S., Reddy J.K. Cooperative formation of higher order peroxisome proliferator-activated receptor and retenoid X receptor complexes on the peroxisome proliferator responsive element of the rat hydratase-dehydrogenase gene. J. Biol. Chem. 270:1995;29636-29639.
38. Aldridge T.C., Tugwood J.D., Green S. Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription. Biochem. J. 306:1995;473-479.
39. Palmer C.N.A., Hsu M.H., Griffin K.J., Johnson E.F. Novel sequence determinants in peroxisome proliferator signaling. J. Biol. Chem. 306:1995;16114-16121.
40. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
41. Vogel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kd trancriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
42. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator P/CIP binds CBP and mediates nuclear-receptor function. Nature (London). 387:1997;677-684.
43. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968.
44. Li H., Gomes P.J., Chen J.D. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc. Natl. Acad. Sci. U. S. A. 94:1997;8479-8484.
45. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/P300. Cell. 90:1997;569-580.
46. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature (London). 389:1997;194-198.
47. Zhu Y., Calandra C., Rao M.S., Reddy J.K. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ Gene Expression. 6:1996;185-195.
48. Zhu Y., Qi C., Jain S., Rao M.S., Reddy J.K. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 41:1997;25500-25506.
49. Yuan C.-X., Ito M., Fondell J.D., Fu Z.-Y., Roeder R.G. The TRAP 220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand dependent fashion. Proc. Natl Acad. Sci. U. S. A. 95:1998;7939-7944.
50. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand dependent transcription activation by nuclear receptors requires the DRIP complex. Nature (London). 398:1999;824-828.
51. Ryu S., Zhou S., Ladurer A.G., Tjian R. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein SPI. Nature (London). 397:1999;446-450.
52. Dowell P., Ishmael J.E., Avram D., Peterson V.J., Nevrivy D.J., Leid M. p300 functions as a coactivator for the peroxisome proliferator-activated receptor. J. Biol. Chem. 272:1997;33435-33443.
53. Puigserver P., Wu Z., Park C.W., Graves R., Wright M., Spiegelman B.M. A cold-inducible coactivator of nuclear receptor linked to adaptive thermogenesis. Cell. 92:1998;829-839.
54. Usuda N., Reddy M.K., Hashimoto T., Rao M.S., Reddy J.K. Tissue specificity and species differences in the distribution of urate oxidase in peroxisomes. Lab. Invest. 58:1988;100-111.
55. Awasthi Y.C., Singh S.V., Goel S.K., Reddy J.K. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator. Biochem. Biophys. Res. Commun. 123:1984;1012-1018.
56. Ciriolo M.R., Mavelli I., Rotilio G., Borzatta V., Cristofari M., Stanzani L. Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidemic drugs. FEBS Lett. 44:1982;264-268.
57. Kasai H., Okada Y., Nishimura S., Rao M.S., Reddy J.K. Formation of 8-hydroxydeoxy-guanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res. 49:1989;2603-2605.
58. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn. J. Cancer Res. 81:1990;213-215.
59. Takagi A., Sai K., Umemura T., Hasegawa R., Kurokawa Y. Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett. 57:1991;55-60.
60. Cattley R.C., Glover S.E. Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization. Carcinogenesis. 14:1993;2495-2499.
61. 32P-postlabeling. Mutat. Res. 247:1991;65-76.
62. Reddy J.K., Lalwani N.D., Reddy M.K., Qureshi S.A. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res. 42:1982;259-266.
63. Goel S.K., Lalwani N.D., Reddy J.K. Peroxisome proliferation and lipid peroxidation in rat liver. Cancer Res. 46:1986;1324-1330.
64. Lake B.G., Kozlen S.L., Evans J.G., Gray T.J.B., Young P.J., Gangolli S.D. Effect of prolonged administration of clofibric acid and di(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology. 44:1987;213-228.
65. Rao M.S., Reddy J.K. Hepatocarcinogenesis of peroxisome proliferators. Ann. N.Y. Acad. Sci. 804:1996;573-587.
66. Hegi M.E., Ulrich D., Sagelsdorff P., Richter C., Lutz W.K. No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline devoid low methionine diet. Mutat. Res. 238:1990;325-329.
67. Rao M.S., Lalwani N.D., Watanabe T.K., Reddy J.K. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res. 44:1984;1072-1076.
68. Ashby J., Brady A., Elcombe C.R., Elliott B.M., Ishmael J., Odum J., Tugwood J.D., Kettle S., Purchase I.F.H. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13(Suppl. 2):1994;S1-S117.
69. Pool B. Diffusion effects in the metabolism of hydrogen peroxide by rat liver peroxisomes. J. Theor. Biol. 51:1975;149-167.
70. 2-generating peroxisomal fatty acyl-CoA oxidase. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7080-7084.
71. 2-generating peroxisomal fatty acyl-CoA oxidase. Int. J. Cancer. 70:1997;716-721.
72. Dadras S.S., Thorgeirsson S.S., Rao M.S., Reddy J.K. Implication of hydrogen peroxide generation and apoptosis in the neoplastic transformation of mouse fibroblasts overexpressing peroxisomal fatty acyl-CoA oxidase. Int. J. Oncol. 12:1998;37-44.
73. Yeldandi A.V., Chu R., Reddy S.K., Pan J., Usuda N., Lin Y., Rao M.S., Reddy J.K. Functional expression and peroxisomal targeting of rat urate oxidase in monkey kidney cells. Gene Expression. 5:1995;123-132.
74. 2-generating peroxisomal urate oxidase. Cancer Res. 56:1996;4846-4852.
75. Suh Y.-A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:1999;79-82.
76. 2 in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6255-6260.
77. Fan C., Pan J., Chu R., Lee D., Kluckman K.D., Usuda N., Singh I., Yeldandi A.V., Rao M.S., Maeda N., Reddy J.K. Hepatocellular and peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271:1996;24698-24710.
78. Fan C., Pan J., Usuda N., Yeldandi A.V., Rao M.S., Reddy J.K. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. J. Biol. Chem. 273:1998;15639-15645.
79. Qi C., Zhu Y., Pan J., Usuda N., Maeda N., Yeldandi A.V., Rao M.S., Hashimoto T., Reddy J.K. Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. J. Biol. Chem. 274:1999;15775-15780.
80. Moody D.E., Rao M.S., Reddy J.K. Mitogenic effect in mouse liver induced by hypolipidemic drug nafenopin. Virchows Arch. Abt. Zell Path. 24:1977;281-296.
81. Reddy J.K., Rao M.S., Azarnoff D.L., Sell S. Mitogenic and carcinogenic effects of hypolipidemic peroxisome proliferator, 4[chloro-6-(2,3-xylidino)-2-pyrimidinylthio)acetic acid (Wy-14,643) in rat and mouse liver. Cancer Res. 39:1979;152-161.
82. Yeldandi A.V., Milano M., Subbarao V., Reddy J.K., Rao M.S. Evaluation of liver cell proliferation during ciprofibrate-induced hepatocarcinogenesis. Cancer Lett. 47:1989;21-27.
83. Reddy J.K., Reddy M.K., Usman M.I., Lalwani N.D., Rao M.S. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate with a hypolipidemic drug. Environ. Health Perspect. 65:1985;317-327.
84. Overturf K., Al-Dhalimy M., Ou C.-N., Finegold M., Grompe M. Serial transplantation reveals the stem-cell like regenerative potential of adult mouse hepatocytes. Am. J. Pathol. 151:1997;1273-1280.
85. David R.M., Moore M.R., Cifone M.A., Finney D.C., Guest D. Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)phthalate and the effects of recovery. Toxicol. Sci. 50:1999;195-205.
86. Mitchell F.E., Price S.C., Hinton R.H., Grasso P., Bridges J.W. Time and dose response study of the effects on rats of the plasticizer di(2-ethylhexyl)phthalate. Toxicol. Appl. Pharmacol. 81:1985;371-392.
87. Cattley R.C., Conway J.G., Popp J.A. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cancer Lett. 38:1987;15-22.
88. Marsman D.S., Cattley R.C., Conway J.G., Popp J.A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate, and 4[chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48:1988;6739-6744.